Array Biopharma (ARRY) trading halted with news pending
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Array Biopharma (NASDAQ: ARRY) trading halted with news pending.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Check Point Software (CHKP) call put ratio 2.4 calls to 1 put into Q4
- General Electric (GE) General Electric (GE) call put ratio 3.5 to 1 put into Q4
- Juno Therapeutics (JUNO) January calls active on takeover speculation
Create E-mail Alert Related CategoriesTrader Talk, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!